Suzhou Kintor Pharmaceuticals
Suzhou
About Suzhou Kintor Pharmaceuticals
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $99.0M
- Funding stage: Late Stage Venture
- Last round: Series D (Oct 2019)
- Website: kintor.com.cn
- Phone: +86-512-62956307
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/suzhou-kintor-pharmaceuticals-19530 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.